Preparation and photothermal therapy of hyaluronic acid–conjugated Au nanoparticle-coated poly (glycidyl methacrylate) nanocomposites
Source abstract
Abstract
Nanocomposites are fabricated with poly (glycidyl methacrylate) (PGMA) microspheres, Au nanoparticles and hyaluronic acid (HA) for accurate photothermal therapy. PGMA microspheres are synthesized by emulsifier-free emulsion polymerization followed by amination. The adsorption of gold seeds is successfully achieved through chelation. PGMA@Au-4 nanocomposites (abbreviated as PGMA@Au) are obtained after gold seed growth. The temperature of the 0.3 mg mL−1 PGMA@Au dispersion increases by 10.6 °C when irradiated with a near-infrared (NIR) laser for 5 min. In order to reduce side effects in normal cells and achieve a specific targeting property for cancer cells, HA is further conjugated on the surface of PGMA@Au (denoted as PGMA@Au–HA). The PGMA@Au–HA nanocomposites perform highly selective targeting toward cancer cells and have good photothermal properties, leading to threefold therapeutic efficacy against cancer cells in comparison with normal cells. These results indicate that the PGMA@Au–HA construct could be a promising platform for cancer therapy.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Angiogenesis and VEGF in Cancer
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–103310.1126/science.1160809 ↗
2. Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331:1559–156410.1126/science.1203543 ↗
3. Crane CH, Macdonald KO, Vauthey J, Yehuda P, Brown T, Curley S, Wong A, Delclos M, Charnsangavej C, Janjan NA (2002) Limitations of conventional doses of chemoradiation for unresectable biliary cancer. Int J Radiat Oncol 53:969–97410.1016/S0360-3016(02)02845-6 ↗
4. Coates A, Abraham S, Kaye SB, Sowerbutts T, Frewin C, Fox R, Tattersall M (1983) On the receiving end—patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 19:203–20810.1016/0277-5379(83)90418-2 ↗
5. Reuther T, Schuster T, Mende U, Kübler A (2003) Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients—a report of a thirty year retrospective review. Int J Oral Max Surg 32:289–29510.1054/ijom.2002.0332 ↗
6. Cheng L, Wang C, Feng L, Yang K, Liu Z (2014) Functional nanomaterials for phototherapies of cancer. Chem Rev 114:10869–1093910.1021/cr400532z ↗
7. Habash RW, Bansal R, Krewski D, Alhafid HT (2006) Thermal therapy, part 1: an introduction to thermal therapy. Crit Rev Biomed Eng 34:459–48910.1615/CritRevBiomedEng.v34.i6.20 ↗
8. Anderson RR, Parrish JA (1983) Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 220:524–52710.1126/science.6836297 ↗
9. Jori G, Spikes JD (1990) Photothermal sensitizers: possible use in tumor therapy. J Photochem Photobiol B 6:93–10110.1016/1011-1344(90)85078-B ↗
10. Faris F, Thorniley M, Wickramasinghe Y, Houston R, Rolfe P, Livera N, Spencer A (1991) Non-invasive in vivo near-infrared optical measurement of the penetration depth in the neonatal head. Clin Phys Physiol Meas 12:353–35810.1088/0143-0815/12/4/005 ↗
11. Abdo A, Sahin M (2007) NIR light penetration depth in the rat peripheral nerve and brain cortex. Presented at 29th annual international conference of the IEEE, Lyon10.1109/IEMBS.2007.4352642 ↗
12. Shanmugam V, Selvakumar S, Yeh C-S (2014) Near-infrared light-responsive nanomaterials in cancer therapeutics. Chem Soc Rev 43:6254–628710.1039/C4CS00011K ↗
13. Liu H, Liu T, Wu X, Li L, Tan L, Chen D, Tang F (2012) Targeting gold nanoshells on silica nanorattles: a drug cocktail to fight breast tumors via a single irradiation with near-infrared laser light. Adv Mater 24:755–76110.1002/adma.201103343 ↗
14. Feng B, Zhou F, Wang D, Xu Z, Yu H, Li Y (2016) Gold nanomaterials for treatment of metastatic cancer. Sci China Chem 59:984–99010.1007/s11426-016-5593-0 ↗
15. Nikoobakht B, El-Sayed MA (2003) Preparation and growth mechanism of gold nanorods (NRs) using seed-mediated growth method. Chem Mater 15:1957–196210.1021/cm020732l ↗
16. Ke H, Wang J, Dai Z, Jin Y, Qu E, Xing Z, Guo C, Yue X, Liu J (2011) Gold-nanoshelled microcapsules: a theranostic agent for ultrasound contrast imaging and photothermal therapy. Angew Chem Int Ed Engl 50:3017–302110.1002/anie.201008286 ↗
17. Ghosh S, Dutta S, Gomes E, Carroll D, D’Agostino R Jr, Olson J, Guthold M, Gmeiner WH (2009) Increased heating efficiency and selective thermal ablation of malignant tissue with DNA-encased multiwalled carbon nanotubes. ACS Nano 3:2667–267310.1021/nn900368b ↗
18. Ji M, Jiang N, Chang J, Sun J (2014) Near-infrared light-driven, highly efficient bilayer actuators based on polydopamine-modified reduced graphene oxide. Adv Funct Mater 24:5412–541910.1002/adfm.201401011 ↗
19. Zhou M, Li J, Liang S, Sood AK, Liang D, Li C (2015) CuS nanodots with ultrahigh efficient renal clearance for positron emission tomography imaging and image-guided photothermal therapy. ACS Nano 9:7085–709610.1021/acsnano.5b02635 ↗
20. Tang S, Chen M, Zheng N (2014) Sub-10-nm Pd nanosheets with renal clearance for efficient near-infrared photothermal cancer therapy. Small 10:3139–314410.1002/smll.201303631 ↗
21. Zhang Z, Shi J, Song Z, Zhu X, Zhu Y, Cao S (2018) A synergistically enhanced photothermal transition effect from mesoporous silica nanoparticles with gold nanorods wrapped in reduced graphene oxide. J Mater Sci 53:1810–1823. https://doi.org/10.1007/s10853-017-1628-y10.1007/s10853-017-1628-y ↗
22. Chen X, Liu Z, Parker SG, Zhang X, Gooding JJ, Ru Y, Liu Y, Zhou Y (2016) Light-induced hydrogel based on tumor-targeting mesoporous silica nanoparticles as a theranostic platform for sustained cancer treatment. ACS Appl Mater Interfaces 8:15857–1586310.1021/acsami.6b02562 ↗
23. Maeda H (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41:189–20710.1016/S0065-2571(00)00013-3 ↗
24. Fang J, Nakamura H, Maeda H (2011) The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63:136–15110.1016/j.addr.2010.04.009 ↗
25. Zhang H, Zhang Y, Wu C, Tan H, Wang S, Zhang B, Zhang Q (2017) Preparation and photothermal study of polystyrene coated with gold nanoshell composite particles. J Mater Sci 52:6581–6590. https://doi.org/10.1007/s10853-017-0893-010.1007/s10853-017-0893-0 ↗
26. Fan X, Jia X, Zhang H, Zhang B, Li C, Zhang Q (2013) Synthesis of raspberry-like poly (styrene–glycidyl methacrylate) particles via a one-step soap-free emulsion polymerization process accompanied by phase separation. Langmuir 29:11730–1174110.1021/la402759w ↗
27. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303–131310.1016/0092-8674(90)90694-A ↗
28. Toole BP (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4:528–53910.1038/nrc1391 ↗
29. Lee Y, Lee H, Kim YB, Kim J, Hyeon T, Park H, Messersmith PB, Park TG (2008) Bioinspired surface immobilization of hyaluronic acid on monodisperse magnetite nanocrystals for targeted cancer imaging. Adv Mater 20:4154–415710.1002/adma.200800756 ↗
30. Fan X, Jia X, Liu J, Liu Y, Zhang H, Zhang B, Zhang H, Zhang Q (2017) Morphology evolution of poly (glycidyl methacrylate) colloids in the 1,1-diphenylethene controlled soap-free emulsion polymerization. Eur Polym J 92:220–23210.1016/j.eurpolymj.2017.03.060 ↗
31. Grabar KC, Allison KJ, Baker BE, Bright RM, Brown KR, Freeman RG, Fox AP, Keating CD, Musick MD, Natan MJ (1996) Two-dimensional arrays of colloidal gold particles: a flexible approach to macroscopic metal surfaces. Langmuir 12:2353–236110.1021/la950561h ↗
32. Culty M, Nguyen HA, Underhill CB (1992) The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 116:1055–106210.1083/jcb.116.4.1055 ↗
33. Eliaz RE, Szoka FC (2001) Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. Cancer Res 61:2592–2601
34. Underhill C, Thurn AL, Lacy BE (1985) Characterization and identification of the hyaluronate binding site from membranes of SV-3T3 cells. J Biol Chem 260:8128–813310.1016/S0021-9258(17)39573-X ↗